Kevin Haas, Ph.D.

Kevin Haas, Ph.D., is Chief Development and Technology Officer at Veracyte. Dr. Haas joined Veracyte in March 2026, and he oversees the company’s global end-to-end product development strategy, spanning diagnostic assay development, software and bioinformatics, as well as the product development program office. He has more than 15 years of life sciences industry experience, leading teams across technology, research, and development. 

Before joining Veracyte, Dr. Haas served as Chief Technology Officer at Myriad, where he led the development of the company’s precision medicine platform and digital health strategy. Prior to that, he held leadership roles in engineering and bioinformatics at both Myriad and Counsyl. He has expertise in creating automated lab technology and AI systems to derive insights from genomics data, and in launching scalable molecular assays. 

 Dr. Haas holds a B.S. from University of Wisconsin-Madison and a Ph.D. in Chemical Engineering from University of California-Berkeley, where he worked on molecular simulation and machine learning to study protein dynamics.